Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
VSee Health ( (VSEE) ) has shared an announcement.
On August 5, 2025, VSee Health, Inc. received a notice from Nasdaq indicating a potential suspension of its stock and warrants due to non-compliance with listing rules, including failure to timely file financial reports and insufficient stockholders’ equity. The company is appealing the decision and plans to address these deficiencies in a hearing scheduled for September 9, 2025. If the appeal is unsuccessful, VSee Health’s securities may be delisted, potentially limiting market access and affecting trading prices.
The most recent analyst rating on (VSEE) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.
VSee Health’s overall stock score is primarily impacted by financial instability and the risk of Nasdaq delisting. Despite revenue growth, the company’s negative equity and bearish technical indicators present significant challenges. The negative valuation metrics further underscore the risks involved.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
VSee Health, Inc. operates in the health industry, focusing on providing telehealth solutions and services.
Average Trading Volume: 766,895
Technical Sentiment Signal: Sell
Current Market Cap: $11M
For an in-depth examination of VSEE stock, go to TipRanks’ Overview page.